rs41279644

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_015634.4(KIFBP):​c.1761T>C​(p.Pro587Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00604 in 1,608,528 control chromosomes in the GnomAD database, including 45 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0051 ( 7 hom., cov: 32)
Exomes 𝑓: 0.0061 ( 38 hom. )

Consequence

KIFBP
NM_015634.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.437

Publications

1 publications found
Variant links:
Genes affected
KIFBP (HGNC:23419): (kinesin family binding protein) This gene encodes a kinesin family member 1 binding protein that is characterized by two tetratrico peptide repeats. The encoded protein localizes to the mitochondria and may be involved in regulating transport of the mitochondria. Mutations in this gene are associated with Goldberg-Shprintzen megacolon syndrome. [provided by RefSeq, Mar 2010]
KIFBP Gene-Disease associations (from GenCC):
  • Goldberg-Shprintzen syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BP6
Variant 10-69016311-T-C is Benign according to our data. Variant chr10-69016311-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 158695.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.437 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0051 (777/152348) while in subpopulation NFE AF = 0.00611 (416/68032). AF 95% confidence interval is 0.00563. There are 7 homozygotes in GnomAd4. There are 448 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 7 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KIFBPNM_015634.4 linkc.1761T>C p.Pro587Pro synonymous_variant Exon 7 of 7 ENST00000361983.7 NP_056449.1
KIFBPXM_017016067.2 linkc.963T>C p.Pro321Pro synonymous_variant Exon 4 of 4 XP_016871556.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KIFBPENST00000361983.7 linkc.1761T>C p.Pro587Pro synonymous_variant Exon 7 of 7 1 NM_015634.4 ENSP00000354848.4 Q96EK5

Frequencies

GnomAD3 genomes
AF:
0.00511
AC:
778
AN:
152230
Hom.:
7
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000892
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00288
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00207
Gnomad FIN
AF:
0.0250
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00613
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00585
AC:
1444
AN:
246692
AF XY:
0.00585
show subpopulations
Gnomad AFR exome
AF:
0.000681
Gnomad AMR exome
AF:
0.00176
Gnomad ASJ exome
AF:
0.000309
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0261
Gnomad NFE exome
AF:
0.00649
Gnomad OTH exome
AF:
0.00404
GnomAD4 exome
AF:
0.00613
AC:
8932
AN:
1456180
Hom.:
38
Cov.:
32
AF XY:
0.00595
AC XY:
4308
AN XY:
724328
show subpopulations
African (AFR)
AF:
0.000908
AC:
30
AN:
33036
American (AMR)
AF:
0.00181
AC:
78
AN:
43044
Ashkenazi Jewish (ASJ)
AF:
0.000310
AC:
8
AN:
25810
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39648
South Asian (SAS)
AF:
0.00227
AC:
195
AN:
85776
European-Finnish (FIN)
AF:
0.0237
AC:
1265
AN:
53328
Middle Eastern (MID)
AF:
0.000349
AC:
2
AN:
5730
European-Non Finnish (NFE)
AF:
0.00641
AC:
7117
AN:
1109726
Other (OTH)
AF:
0.00394
AC:
237
AN:
60082
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
496
992
1489
1985
2481
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
264
528
792
1056
1320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00510
AC:
777
AN:
152348
Hom.:
7
Cov.:
32
AF XY:
0.00601
AC XY:
448
AN XY:
74508
show subpopulations
African (AFR)
AF:
0.000890
AC:
37
AN:
41592
American (AMR)
AF:
0.00287
AC:
44
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00207
AC:
10
AN:
4828
European-Finnish (FIN)
AF:
0.0250
AC:
265
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00611
AC:
416
AN:
68032
Other (OTH)
AF:
0.00237
AC:
5
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
39
78
118
157
196
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00540
Hom.:
5
Bravo
AF:
0.00327
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00447
EpiControl
AF:
0.00439

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Jan 23, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Sep 11, 2020
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Jun 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

KIFBP: BP4, BP7, BS2 -

Dec 21, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Goldberg-Shprintzen syndrome Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.60
CADD
Benign
5.7
DANN
Benign
0.66
PhyloP100
-0.44
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41279644; hg19: chr10-70776067; API